Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

被引：0
作者：
N. Vasdev
H. Zargar
J. P. Noël
R. Veeratterapillay
A. S. Fairey
L. S. Mertens
C. P. Dinney
M. C. Mir
L. M. Krabbe
M. S. Cookson
N. E. Jacobsen
N. M. Gandhi
J. Griffin
J. S. Montgomery
E. Y. Yu
E. Xylinas
N. J. Campain
W. Kassouf
M. A. Dall’Era
J. A. Seah
C. E. Ercole
S. Horenblas
S. S. Sridhar
J. S. McGrath
J. Aning
S. F. Shariat
J. L. Wright
T. M. Morgan
T. J. Bivalacqua
S. North
D. A. Barocas
Y. Lotan
P. Grivas
A. J. Stephenson
J. B. Shah
B. W. van Rhijn
S. Daneshmand
P. E. Spiess
J. M. Holzbeierlein
A. Thorpe
P. C. Black
机构：
[1] Lister Hospital,Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre
[2] University of Hertfordshire,School of Life and Medical Sciences
[3] Freeman Hospital,Department of Urology
[4] Royal Melbourne Hospital,Department of Urology
[5] University of Melbourne,Department of Surgery
[6] University of British Columbia,Department of Urologic Sciences
[7] H. Lee Moffitt Cancer Center and Research Institute,Department of Genitourinary Oncology
[8] University of Southern California,USC/Norris Comprehensive Cancer Center, Institute of Urology
[9] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Urology
[10] MD Anderson Cancer Center,Department of Urology
[11] University of Texas Southwestern Medical Center,Department of Urology
[12] University of Oklahoma College of Medicine,Department of Urology
[13] University of Alberta,Department of Urology
[14] The Johns Hopkins School of Medicine,Department of Urology, Medical Center
[15] The James Buchanan Brady Urological Institute,Department of Urology
[16] University of Kansas,Division of Oncology, Department of Medicine
[17] University of Michigan Health System,Department of Urology, Weill Cornell Medical College
[18] University of Washington School of Medicine and Fred Hutchinson Cancer Research Center,Department of Urology
[19] Presbyterian Hospital,Department of Surgery, Exeter Surgical Health Services Research Unit
[20] Vienna General Hospital,(Division of Urology) Department of Surgery
[21] Medical University of Vienna,Department of Urology
[22] Royal Devon and Exeter NHS Trust,Department of Urologic Surgery
[23] McGill University Health Center,undefined
[24] Davis Medical Center,undefined
[25] University of California at Davis,undefined
[26] Princess Margaret Cancer Center,undefined
[27] Cross Cancer Institute,undefined
[28] Vanderbilt University Medical Center,undefined
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Neoadjuvant chemotherapy; Carcinoma insitu; Bladder cancer; Radical cystectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：165 / 172
页数：7
相关论文
共 312 条
  • [1] Grossman HB(2003)Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859-866
  • [2] Natale RB(2015)Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 67 241-249
  • [3] Tangen CM(2016)Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1 J Urol 195 886-893
  • [4] Speights VO(2009)Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series Cancer 115 792-799
  • [5] Vogelzang NJ(2014)Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma Cancer Discov 4 1140-1153
  • [6] Trump DL(2015)Defects in DNA repair genes predict response to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer Eur Urol 68 959-967
  • [7] deVere White RW(2015)Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy Eur Urol 68 959-967
  • [8] Sarosdy MF(2016)Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma JAMA Oncol 2 1094-1096
  • [9] Wood DP(2014)Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy Cancer Cell 25 152-165
  • [10] Raghavan D(2014)Novel neoadjuvant therapy paradigms for bladder cancer: results from the national cancer center institute forum Urol Oncol 32 1108-1115
12345678910